Literature DB >> 16854751

Critical factors determining the potency of topical corticosteroids.

Ryan Kirkland, Daniel J Pearce, Rajesh Balkrishnan, Steven R Feldman.   

Abstract

The vasoconstrictor assay is a highly reliable method used to determine the bioequivalence of topical corticosteroid preparations. By assessing skin blanching, the assay describes the delivery of the active agent through the skin barrier, intrinsic activity at the receptor, and the rate of clearance from the site of application. Vasoconstrictor rankings are generally good predictors of efficacy in clinical trials. Vasoconstrictor assays are not as predictive of outcomes in clinical practice because these assays do not account for a critical factor: how well patients use the medication. Patient compliance plays a vital role in corticosteroid potency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854751     DOI: 10.1080/09546630600845370

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  1 in total

1.  Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments.

Authors:  C Queille-Roussel; B Bang; F Clonier; J-P Lacour
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-06-15       Impact factor: 6.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.